Search

Displaying results 7381 - 7390 of 10000 in total
  1. Drug

    PRO-1562

    go.drugbank.com/drugs/DB33979
    Experimental

    PRO-1562 is under investigation in clinical trial NCT07826689 (A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis). … PRO-1562 is a small molecule drug.

  2. Drug

    Fluprednidene

    go.drugbank.com/drugs/DB08970
    Experimental

    Fluprednidene is a corticosteroid.

    Categories: Corticosteroids, Moderately Potent (Group II)
  3. Drug

    SLV-334

    go.drugbank.com/drugs/DB15356
    Investigational

    SLV-334 is under investigation in clinical trial NCT00735085 (A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.).

  4. Drug

    Flovagatran

    go.drugbank.com/drugs/DB05714
    Experimental

  5. Drug

    Thrombopoietin

    go.drugbank.com/drugs/DB06534
    Investigational

  6. Drug

    Estradiol sulfamate

    go.drugbank.com/drugs/DB06597
    Investigational

  7. Drug

    Ilepatril

    go.drugbank.com/drugs/DB06604
    Investigational

  8. Drug

    Clazosentan

    go.drugbank.com/drugs/DB06677
    Investigational

    Categories: Receptor, Endothelin A
  9. Drug

    Ruserontinib

    go.drugbank.com/drugs/DB21555
    Investigational

    Ruserontinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Ruserontinib is a tyrosine kinase inhibitor. … Ruserontinib is under investigation in clinical trial NCT04716114 (A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated).

  10. Drug

    Enbezotinib

    go.drugbank.com/drugs/DB21565
    Investigational

    Enbezotinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Enbezotinib is a tyrosine kinase inhibitor. … Enbezotinib is under investigation in clinical trial NCT04161391 (Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations).